Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer
Technology appraisal guidance
Reference number: TA638
Published:
The date for the third discussion of Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer is yet to be confirmed. The details will be updated once it has been scheduled.